-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Other Antiretrovirals in Development
See also: HIV Drugs in Development
Other Drugs
- Suppression of Human Protein Reduces HIV's Ability to Enter T Cells, Replicate, Study Finds (April 30, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Not Your Everyday Antiretroviral: KP-1461, an HIV DNA Killer (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News - Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says (April 20, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Gilead's Fixed-Dose Combination of Truvada + Efavirenz Not Yet Bioequivalent to Drugs Alone (August 10, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - New Vulnerability Found in AIDS Virus, German Scientists Say (August 3, 2005)
In vitro tests find that a peptide appears to halt HIV assembly.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Tat Inhibitors, a New Approach: Interview With Olaf Kutsch, Ph.D. (February 28, 2005)
Years ago, a Tat inhibitor worked well in the lab but failed in patients; modern biotechnology, however, may give the drug new life.
In AIDS Treatment News, from AIDS Treatment News - Behind the December 2004 "AIDS Breakthrough" Headlines (December 31, 2004)
Mid-December press reports were exaggerated, but still important; they focus on DAPYs, a promising new family of HIV meds.
In AIDS Treatment News, from AIDS Treatment News - Statins May Help Treat HIV (October 2004)
Quick recap of a recent study on Mevacor in the Journal of Experimental Medicine.
To read PDF, click here
In HIV Treatment ALERTS!, from The Center for AIDS - Treatment of HIV Infection With Prednisolone (July 13, 2004)
In The XV International AIDS Conference, from The Body PRO - Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases - Capsid Protein Assembly Inhibitors: Potential New Class of Antiviral Drugs (May 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Discovery Lays Groundwork for Potential New Class of Anti-HIV Drugs (March 31, 2003)
From U.S. National Institute of Allergy and Infectious Diseases - Digging Deeper at the Resistance Workshop (August 14, 2002)
Key clinical findings from July's XI International HIV Drug Resistance Workshop.
From International AIDS Society - New Cancer Drugs Might Help Treat HIV -- But Research Not Done (April 12, 2002)
In AIDS Treatment News, from AIDS Treatment News - New Immune-Based Treatment Approach: Trial Recruiting in San Francisco (February 23, 2001)
In AIDS Treatment News, from AIDS Treatment News
  |